Pay in 4 interest-free payments of $100.62 Learn more
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3
individually pouched
that meet the requirements to perform moderate
The GenBody COVID-19 Ag is an immunochromatographic rapid diagnostic test (RDT) intended for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2 in direct nasopharyngeal (NP) or anterior nasal (AN) swab specimens from individuals who are suspected of COVID-19 by their healthcare provider within the first six days of symptom onset
SARS-CoV-2
Status COVID-19/Flu A&B Rapid Antigen Test (33225) dip stick individually pouchedStatus COVID 19 Flu A&B test is a lateral flow immunoassay intended for the in vitro rapid, simultaneous qualitative detection and differentiation of nucleocapsid antigen from SARS CoV 2, influenza A and or influenza B directly from nasopharyngeal swab specimens obtained from individuals, who are suspected of respiratory viral infection consistent with COVID 19 by their healthcare provider, within the first five days of onset of symptoms. Product